Search
Now showing items 11-11 of 11
Enhancement of gemcitabine against pancreatic cancer by loading in mesoporous silica vesicles
(
Elsevier B.V.
, 2017 , Article)
Gemcitabine (Gem) is currently the first-line chemotherapeutic drug in management of pancreatic cancer, however the therapeutic efficacy of Gem is limited due to its short half-life and poor cell membrane permeability. ...